First Eagle Investment Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
2,314,614
+48,371
+2% +$254K 0.02% 222
2026
Q1
$9.47M Buy
2,266,243
+136,693
+6% +$658K 0.02% 192
2025
Q4
$10.2M Buy
2,129,550
+336,199
+19% +$1.63M 0.02% 171
2025
Q3
$9.07M Buy
1,793,351
+439,731
+32% +$1.94M 0.02% 178
2025
Q2
$5.46M Buy
1,353,620
+225,800
+20% +$735K 0.01% 246
2025
Q1
$3.08M Buy
1,127,820
+591,866
+110% +$2.12M 0.01% 303
2024
Q4
$2.28M Buy
+535,954
New +$2.04M 0.01% 321

Other funds holding SRTA

First Eagle Investment Management's SRTA Position: Q2 2026 in Review

First Eagle Investment Management increased its Strata Critical Medical Inc (SRTA) stake by 2.1% in Q2 2026, buying an estimated $254K and bringing the position to 2,314,614 shares worth $12.2M. The position accounts for 0.02% of the portfolio, ranked #222.

First Eagle Investment Management first reported a position in SRTA in Q4 2024 and has held it in 7 quarters since. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • First Eagle Investment Management held 2,314,614 shares of Strata Critical Medical Inc worth $12.2M as of Q2 2026.
  • First Eagle Investment Management bought 48,371 Strata Critical Medical Inc shares in Q2 2026, an estimated $254K.
  • Strata Critical Medical Inc made up 0.02% of First Eagle Investment Management's portfolio in Q2 2026, its #222 holding.
  • First Eagle Investment Management first reported a position in Strata Critical Medical Inc in Q4 2024 and has held it in 7 quarters since.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on First Eagle Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.